Interestingly, a recent in silico study conducted on The Cancer Genome Atlas (TCGA) reveals 4-lncRNA signature correlated to the immunotherapy response in 71 melanoma patients [99]; likewise, 15-lncRNA signature was found in 92 melanoma patients associated with a anti-PD-1 monotherapy response [100]. The gene discussed is PDCD1; the disease is melanoma.